ADV/HSV-tk (gene therapy)

DRUG2 trials

Sponsors

David Baskin MD, The Methodist Hospital Research Institute

Conditions

Anaplastic AstrocytomaAstrocytoma, Grade IIIGlioblastomaGlioblastoma Multiforme

Phase 1

HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM

RecruitingNCT03596086

David Baskin MDAstrocytoma, Grade III, Glioblastoma Multiforme

Start: 2017-12-11End: 2026-12-30Target: 62Updated: 2026-03-30

HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM

RecruitingNCT03603405

The Methodist Hospital Research InstituteAnaplastic Astrocytoma, Glioblastoma

Start: 2018-02-28End: 2026-12-31Target: 62Updated: 2026-03-30

Related Papers

Combined cytotoxic and immune-stimulatory gene therapy using Ad-TK and Ad-Flt3L: Translational developments from rodents to glioma patients.

2023-08-1214 citations